bf/NASDAQ:BIIB_icon.jpeg

NASDAQ:BIIB

Biogen Inc.

  • Stock

120.93

−0.12%

−18.19

USD last updated 22/08 01:43:23

Last Close

139.12

21/08 21:56

Market Cap

33.89B

Beta: 0.19

Volume Today

2.32M

Avg: 876.67K

PE Ratio

24.00

PFCF: 34.22

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
9.70B
-
10.76B
10.93%
11.45B
6.36%
12.27B
7.21%
13.45B
9.61%
14.38B
6.88%
13.44B
6.49%
10.98B
18.32%
10.17B
7.36%
9.84B
3.32%
9.68B
1.62%
cost of revenue
1.17B
-
1.24B
5.92%
1.48B
19.21%
1.63B
10.23%
1.82B
11.43%
1.96B
7.66%
1.81B
7.68%
2.11B
16.87%
2.28B
7.99%
2.53B
11.20%
2.31B
8.80%
gross profit
8.53B
-
9.52B
11.62%
9.97B
4.69%
10.64B
6.76%
11.64B
9.33%
12.42B
6.75%
11.64B
6.30%
8.87B
23.78%
7.90B
11.01%
7.30B
7.51%
7.37B
0.87%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
2.23B
-
2.11B
5.34%
1.95B
7.82%
1.94B
0.64%
2.11B
8.82%
2.37B
12.74%
2.50B
5.47%
2.67B
6.78%
2.40B
10.12%
2.55B
6.08%
2.40B
5.73%
research and development expenses
1.89B
-
2.01B
6.30%
1.97B
1.96%
2.25B
14.20%
2.60B
15.25%
2.28B
12.19%
3.99B
74.99%
2.50B
37.33%
2.23B
10.80%
2.46B
10.35%
2.04B
17.07%
other expenses
-25.78M
-
-123.70M
379.81%
-217.40M
75.75%
-215.40M
0.92%
11M
105.11%
731.50M
6,550%
697.70M
4.62%
888.50M
27.35%
358.50M
59.65%
-3.50M
100.98%
701.10M
20,131.43%
cost and expenses
5.79B
-
5.75B
0.65%
5.80B
0.81%
6.75B
16.40%
7.45B
10.47%
7.34B
1.47%
9.00B
22.56%
8.17B
9.16%
7.27B
11.04%
8.00B
10.08%
7.46B
6.84%
operating expenses
4.62B
-
4.51B
2.32%
4.32B
4.25%
5.12B
18.51%
5.64B
10.16%
5.39B
4.42%
7.19B
33.53%
6.06B
15.70%
4.99B
17.66%
5.47B
9.57%
5.15B
5.93%
interest expense
29.50M
-
95.50M
223.73%
260M
172.25%
250.80M
3.54%
200.60M
20.02%
187.40M
6.58%
222.50M
18.73%
253.60M
13.98%
246.60M
2.76%
246.90M
0.12%
250.30M
1.38%
ebitda
4.35B
-
5.52B
26.90%
6.54B
18.47%
6.53B
0.23%
6.86B
5.12%
7.52B
9.60%
4.81B
36.06%
3.66B
23.94%
2.69B
26.54%
2.60B
3.25%
2.83B
8.87%
operating income
3.97B
-
4.89B
23.12%
5.15B
5.30%
5.34B
3.76%
5.89B
10.19%
7.04B
19.60%
4.55B
35.39%
2.84B
37.57%
2.32B
18.32%
1.30B
44.11%
2.22B
71.11%
depreciation and amortization
489.76M
-
382.60M
21.88%
385.60M
0.78%
814.70M
111.28%
747.30M
8.27%
476.10M
36.29%
257.20M
45.98%
815.90M
217.22%
365.90M
55.15%
494.80M
35.23%
673.20M
36.05%
total other income expenses net
29.87M
-
-247.60M
928.93%
-720.10M
190.83%
-399M
44.59%
-101.20M
74.64%
83.30M
182.31%
497.40M
497.12%
-1.10B
320.25%
1.27B
216.07%
-563.90M
144.35%
-312.90M
44.51%
income before tax
3.95B
-
4.77B
20.79%
4.93B
3.48%
5.13B
3.97%
5.90B
15.03%
7.13B
20.79%
5.05B
29.17%
1.75B
65.42%
3.59B
105.81%
1.30B
63.90%
1.91B
46.98%
income tax expense
989.94M
-
1.16B
17.34%
1.24B
6.52%
2.46B
98.71%
1.43B
42.02%
1.16B
18.77%
992.30M
14.31%
52.50M
94.71%
632.80M
1,105.33%
135.30M
78.62%
273.80M
102.37%
net income
2.93B
-
3.55B
20.86%
3.70B
4.39%
2.54B
31.43%
4.43B
74.50%
5.89B
32.90%
4.00B
32.06%
1.56B
61.10%
3.05B
95.80%
1.16B
61.89%
1.63B
40.57%
weighted average shs out
236.36M
-
230.70M
2.39%
218.40M
5.33%
212.60M
2.66%
204.90M
3.62%
187.10M
8.69%
160.90M
14.00%
149.10M
7.33%
145.30M
2.55%
144.70M
0.41%
145.70M
0.69%
weighted average shs out dil
237.18M
-
231.20M
2.52%
218.80M
5.36%
213M
2.65%
205.30M
3.62%
187.40M
8.72%
161.30M
13.93%
149.60M
7.25%
146M
2.41%
145.60M
0.27%
145.90M
0.21%
eps
12.42
-
15.38
23.83%
16.96
10.27%
11.94
29.60%
21.62
81.07%
31.47
45.56%
24.86
21.00%
10.44
58.00%
20.96
100.77%
8.02
61.74%
11.20
39.65%
epsdiluted
12.37
-
15.34
24.01%
16.93
10.37%
11.92
29.59%
21.58
81.04%
31.42
45.60%
24.80
21.07%
10.40
58.06%
20.87
100.67%
7.97
61.81%
11.19
40.40%

All numbers in USD (except ratios and percentages)